Label: KETOCONAZOLE aerosol, foam

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated December 24, 2024

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use KETOCONAZOLE FOAM safely and effectively. See full prescribing information for KETOCONAZOLE FOAM. KETOCONAZOLE foam, 2% For ...
  • Table of Contents
    Table of Contents
  • 1 INDICATIONS AND USAGE
    Ketoconazole foam, 2% is indicated for the topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older. Limitations of Use - Safety and efficacy of ...
  • 2 DOSAGE AND ADMINISTRATION
    Ketoconazole foam, 2% should be applied to the affected area(s) twice daily for four weeks. Hold the container upright, and dispense ketoconazole foam, 2% into the cap of the can or other cool ...
  • 3 DOSAGE FORMS AND STRENGTHS
    Ketoconazole foam, 2% contains 20 mg of ketoconazole, USP per gram, supplied in 50 g and 100 g containers.
  • 4 CONTRAINDICATIONS
    None.
  • 5 WARNINGS AND PRECAUTIONS
    5.1 Contact Sensitization - Ketoconazole foam, 2% may result in contact sensitization, including photoallergenicity [see Adverse Reactions (6.2)]. 5.2 Flammable Contents - The contents of ...
  • 6 ADVERSE REACTIONS
    6.1 Clinical Trials Experience - Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly ...
  • 8 USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Risk Summary - There are no available data on ketoconazole foam, 2% use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage or adverse ...
  • 11 DESCRIPTION
    Ketoconazole foam, 2% contains 2% ketoconazole USP, an antifungal agent, in a thermolabile hydroethanolic foam for topical application. The chemical name for ketoconazole is piperazine ...
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - The mechanism of action of ketoconazole in the treatment of seborrheic dermatitis is not known. 12.2 Pharmacodynamics - The pharmacodynamics of ketoconazole foam, 2 ...
  • 13 NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility - Long-term animal studies have not been performed to evaluate the carcinogenic or photo-carcinogenic potential of ketoconazole foam ...
  • 14 CLINICAL STUDIES
    The safety and efficacy of ketoconazole foam, 2% were evaluated in a randomized, double-blind, vehicle-controlled trial in subjects 12 years and older with mild to severe seborrheic dermatitis. In ...
  • 16 HOW SUPPLIED/STORAGE AND HANDLING
    Ketoconazole Foam, 2% contains 20 mg of ketoconazole, USP per gram. The thermolabile hydroethanolic foam is available as follows: NDC: 72162-1417-1: 100 g aluminum can - NDC: 72162-1417-2: 50 g ...
  • 17 PATIENT COUNSELING INFORMATION
    See FDA-approved patient labeling (Patient Package Insert). Instruct patients on a proper use of ketoconazole foam, 2%. • Avoid fire, flame and/or smoking during and immediately following ...
  • SPL UNCLASSIFIED SECTION
    Manufactured by Padagis® Yeruham, Israel - www.padagis.com - Rev 02-24 - 5K200 RC PH6 - Product of India
  • PATIENT INFORMATION
    Ketoconazole Foam, 2% Important Information: Ketoconazole foam, 2% is for use on the skin only. Do not use ketoconazole foam, 2% in your eyes, mouth or vagina. What is ketoconazole foam ...
  • Instructions for Use
    Ketoconazole Foam, 2% Important Information: Ketoconazole foam, 2% is for use on the skin only. Do not use ketoconazole foam, 2% in your eyes, mouth or vagina. Step 1: Remove the clear cap ...
  • PRINCIPAL DISPLAY PANEL
    Ketoconazole 2% Foam
  • INGREDIENTS AND APPEARANCE
    Product Information